Skip to main content
. 2019 May 8;12:1756286419843458. doi: 10.1177/1756286419843458

Table 5.

Comparison between responder and nonresponder Parkinson’s disease patients, treated with mirabegron 50 mg/day at the 3-month follow up.

Responders
n = 24
Nonresponders
n = 4

p
Neurological disease duration, years 7.9 ± 4.1 12.5 ± 3.7 p = 0.04
Hoehn–Yahr score 2.5 ± 0.9 3.3 ± 1.1 p = 0.068

Values are expressed as mean ± SD.

SD, standard deviation.